These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22778861)

  • 1. ACS chemical neuroscience molecule spotlight on gilenya (fingolimod; FTY720).
    Hopkins CR
    ACS Chem Neurosci; 2011 Mar; 2(3):116-7. PubMed ID: 22778861
    [No Abstract]   [Full Text] [Related]  

  • 2. FTY720 and central memory: out of sight, out of mind.
    Slavin AJ; Zamvil SS
    Neurology; 2010 Aug; 75(5):388-9. PubMed ID: 20610831
    [No Abstract]   [Full Text] [Related]  

  • 3. Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis.
    Chiba K; Adachi K
    Future Med Chem; 2012 Apr; 4(6):771-81. PubMed ID: 22530640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of fingolimod (FTY720) in neuroimmunologic diseases: mechanisms beyond immunomodulation.
    Haghikia A; Gold R
    Am J Pathol; 2010 Jun; 176(6):2599-601. PubMed ID: 20395429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial watch: Phase III promise for oral multiple sclerosis therapy.
    Nat Rev Drug Discov; 2009 Feb; 8(2):98. PubMed ID: 19180099
    [No Abstract]   [Full Text] [Related]  

  • 6. [FTY720 (Fingolimod) as a new therapeutic option for multiple sclerosis].
    Klatt J; Hartung HP; Hohlfeld R
    Nervenarzt; 2007 Oct; 78(10):1200-8. PubMed ID: 17668161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).
    Chun J; Brinkmann V
    Discov Med; 2011 Sep; 12(64):213-28. PubMed ID: 21955849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fingolimod - a new immunomodulator].
    Friedrich FW; Eschenhagen T
    Dtsch Med Wochenschr; 2009 Oct; 134(42):2127-31. PubMed ID: 19809964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis in 2010: Advances in monitoring and treatment of multiple sclerosis.
    Filippi M
    Nat Rev Neurol; 2011 Feb; 7(2):74-5. PubMed ID: 21297650
    [No Abstract]   [Full Text] [Related]  

  • 10. Current perspectives on FTY720.
    Martini S; Peters H; Böhler T; Budde K
    Expert Opin Investig Drugs; 2007 Apr; 16(4):505-18. PubMed ID: 17371198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent trials for FTY720 (fingolimod): a new generation of immunomodulators structurally similar to sphingosine.
    Mansoor M; Melendez AJ
    Rev Recent Clin Trials; 2008 Jan; 3(1):62-9. PubMed ID: 18474015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs may improve, complicate treatment for multiple sclerosis.
    Link H; Martin R
    Nat Med; 2010 Mar; 16(3):272. PubMed ID: 20208513
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple sclerosis, immunomodulation, and immunizations: balancing the benefits.
    Goldman MD; Naismith RT
    Neurology; 2015 Mar; 84(9):864-5. PubMed ID: 25636716
    [No Abstract]   [Full Text] [Related]  

  • 14. Ventricular tachycardia on chronic fingolimod treatment for multiple sclerosis.
    Castillo-Trivino T; Lopetegui I; Alarcón-Duque JA; López de Munain A; Olascoaga J
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):931-2. PubMed ID: 25835036
    [No Abstract]   [Full Text] [Related]  

  • 15. [A plan for risk management in the treatment of multiple sclerosis with gilenia (fingolimod)].
    Popova NF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(2 Pt 2):110-3. PubMed ID: 21916166
    [No Abstract]   [Full Text] [Related]  

  • 16. [New, effective immunomodulatory drug in treatment of multiple sclerosis: the fingolimod].
    Komoly S
    Ideggyogy Sz; 2012 Nov; 65(11-12):421-2. PubMed ID: 23289178
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sclerosis: Cladribine--a contentious therapeutic contender for MS.
    Hohlfeld R
    Nat Rev Neurol; 2011 Jul; 7(8):425-7. PubMed ID: 21750524
    [No Abstract]   [Full Text] [Related]  

  • 18. Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis.
    Ward MD; Jones DE; Goldman MD
    Expert Opin Drug Saf; 2014 Jul; 13(7):989-98. PubMed ID: 24935480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The curtain is drawn for both natalizumab and fingolimod (FTY720): a new era of multiple sclerosis therapy has arrived.
    Weissert R
    Expert Rev Neurother; 2006 Nov; 6(11):1587-90. PubMed ID: 17144774
    [No Abstract]   [Full Text] [Related]  

  • 20. [New therapeutic approach for autoimmune diseases by the sphingosine 1-phosphate receptor modulator, fingolimod (FTY720)].
    Chiba K
    Yakugaku Zasshi; 2009 Jun; 129(6):655-65. PubMed ID: 19483408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.